Abciximab |
No (n= 91) |
Yes (n= 48 ) |
p |
Baseline stenosis |
74.88 ± 12.3 |
76.47 ± 9.2 |
0. 446 |
Poststent stenosis |
14.87 ± 16.1 |
15.40 ± 12.8 |
0. 851 |
Reference lumen diameter |
2.77 ± 0.6 |
2.86 ± 0.6 |
0. 423 |
Maximum stent diameter |
3.04 ± 0.5 |
2.94 ± 0.3 |
0. 273 |
Ostial lesion |
20 (22) |
14 (29) |
0. 510 |
Bifurcated lesion |
35 (38.5) |
24 (50) |
0. 347 |
IABP |
1 (1) |
2 (4) |
0. 499 |
Pacemaker |
2 (2.2) |
1 (2.1) |
0. 718 |
Fluroscopy (min) |
28 ± 12 |
33 ± 16 |
0. 055 |
Contrast (ml) |
319 ± 126 |
291 ± 113 |
0. 249 |
DES |
77 (84.6) |
40 (83.3) |
0. 844 |
Number of treated vessel |
1.033 ± 0.2 |
1.06 ± 0.2 |
0. 487 |
Stent length |
45.28 ± 26 |
45.6 ± 27 |
0. 947 |
Burr Size |
1.65 ± 0.21 |
1.58 ± 0.16 |
0. 086 |
LM Treated |
25 (27.5) |
12 (25) |
0. 698 |
Inotropes |
4 (4.4) |
1 (2.1) |
0. 710 |
Slow/No reflow |
3 (3.3) |
0 |
0. 444 |
Branch loss (> 2 mm) |
2 (2.2) |
2 (4.2) |
0. 718 |
DES: Drug Eluting Stent; IABP: Intraortic Balloon Pump |